Correlation Between Inhibrx and Fortune Rise
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Fortune Rise at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Fortune Rise into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Fortune Rise Acquisition, you can compare the effects of market volatilities on Inhibrx and Fortune Rise and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Fortune Rise. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Fortune Rise.
Diversification Opportunities for Inhibrx and Fortune Rise
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Inhibrx and Fortune is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Fortune Rise Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortune Rise Acquisition and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Fortune Rise. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortune Rise Acquisition has no effect on the direction of Inhibrx i.e., Inhibrx and Fortune Rise go up and down completely randomly.
Pair Corralation between Inhibrx and Fortune Rise
Given the investment horizon of 90 days Inhibrx is expected to under-perform the Fortune Rise. In addition to that, Inhibrx is 5.21 times more volatile than Fortune Rise Acquisition. It trades about -0.1 of its total potential returns per unit of risk. Fortune Rise Acquisition is currently generating about 0.16 per unit of volatility. If you would invest 1,133 in Fortune Rise Acquisition on September 19, 2024 and sell it today you would earn a total of 36.00 from holding Fortune Rise Acquisition or generate 3.18% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 61.9% |
Values | Daily Returns |
Inhibrx vs. Fortune Rise Acquisition
Performance |
Timeline |
Inhibrx |
Fortune Rise Acquisition |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Good
Inhibrx and Fortune Rise Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and Fortune Rise
The main advantage of trading using opposite Inhibrx and Fortune Rise positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Fortune Rise can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortune Rise will offset losses from the drop in Fortune Rise's long position.Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Fortune Rise vs. The Coca Cola | Fortune Rise vs. Inhibrx | Fortune Rise vs. PepsiCo | Fortune Rise vs. Molson Coors Brewing |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |